🇪🇺 Revex in European Union

Revex (NALMEFENE) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/002583
  • Local brand name: Selincro
  • Status: approved

Revex in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in European Union

Frequently asked questions

Is Revex approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Revex in European Union?

Hikma is the originator. The local marketing authorisation holder may differ — check the official source linked above.